Epithelix Sàrl is a Swiss biotech company specialized in human tissue engineering. Epithelix provides innovative R&D solutions for the study of human respiratory diseases (e.g. Asthma, COPD, Cystic Fibrosis, etc.) and for inhalation toxicity testing of chemicals, while reducing the number of animal experiments.
Looking for a particular Epithelix employee's phone or email?
Epithelix Questions
The Epithelix annual revenue was $4 million in 2026.
Samuel Constant is the Co-founder and Chief Executive Officer of Epithelix.
16 people are employed at Epithelix.
The NAICS codes for Epithelix are [541713, 541, 54171, 54, 5417].
The SIC codes for Epithelix are [87, 873].
Top Epithelix Employees
-
Samuel Constant
Co-founder and Chief Executive Officer at Epithelix
Plan-les-Ouates, GE, CH2 -
Ludovic Wiszniewski
CEO at Epithelix
Geneva, GE, CH15+ -
Bernadett Boda
Research and Development Scientist at Epithelix
Geneva, Switzerland1 -
Mireille Caul-Futy
Responsable de laboratoire at Epithelix
Mont-Saxonnex, Auvergne-Rhône-Alpes, FR1 -
Guy Barbin
Research Associate at Epithelix
Geneva, Switzerland1 -
Xiao-Yann H
Customer assitant manager at Epithelix
Geneva, GE, CH -
11
-
Nicolas Simonnet
Responsable informatique at Epithelix
Plan-les-Ouates, GE, CH21
Related Companies
